⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20437367 | 0.69 | — | — | |
| SCHEMBL18800433 | 0.64 | — | — | |
| Ammonia Solution, Strong SCHEMBL3830975 | 0.62 | — | — | |
| SCHEMBL16596098 | 0.56 | LMNA (0.36) | — | |
| SCHEMBL3078296 | 0.56 | — | — | |
| SCHEMBL5538228 | 0.56 | — | — | |
| SCHEMBL245730 | 0.56 | — | — | |
| SCHEMBL10095236 | 0.56 | — | — | |
| SCHEMBL10097228 | 0.56 | — | — | |
| SCHEMBL20227657 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4389145-A2 | INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES | Ambrx, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3488870-B1 | ANTI-CD70 ANTIBODY DRUG CONJUGATES | AMBRX INC (US) | 2024-03-20 | — | — | EP | disclosed |
| EP-3225248-B1 | MODIFIED BOVINE G-CSF POLYPEPTIDES AND THEIR USES | AMBRX INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230028168-A1 | Modified Relaxin Polypeptides and Their Uses | AMBRX, INC. | 2023-01-26 | — | — | US | disclosed |
| WO-2022212899-A1 | ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF | AMBRX, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| US-11344626-B2 | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use | SUTRO BIOPHARMA, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2021183832-A1 | INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF | AMBRX, INC. (US) | 2021-09-16 | — | — | WO | disclosed |
| EP-3170821-B1 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES | AMBRX INC (US) | 2021-09-15 | — | — | EP | disclosed |
| US-20200299403-A1 | ANTIBODIES COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | SUTRO BIOPHARMA, INC. | 2020-09-24 | — | — | US | disclosed |
| US-20200283543-A1 | MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | SUTRO BIOPHARMA INC (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3505534-A1 | ANTIBODIES COMPRISING SITESPECIFIC NONNATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. (US) | 2019-07-03 | — | — | EP | disclosed |
| EP-3336103-A1 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| US-20180036425-A1 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | SUTRO BIOPHARMA INC (US) | 2018-02-08 | — | — | US | disclosed |
| EP-3225248-A1 | MODIFIED BOVINE G-CSF POLYPEPTIDES AND THEIR USES | Ambrx, Inc. (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9764039-B2 | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use | SUTRO BIOPHARMA, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| EP-3170821-A1 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES | Ambrx, Inc. (US) | 2017-05-24 | — | — | EP | disclosed |
| EP-3135690-A1 | MODIFIED FC PROTEINS COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES OF THE SAME, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. (US) | 2017-03-01 | — | — | EP | disclosed |